Investigators led by Barbara Stranger, PhD, associate professor of Pharmacology, developed a guide outlining best practices for studying and testing sex-dependent genetic effects in complex traits and diseases, published in the journal Cell.
Northwestern University Feinberg School of Medicine has again been recognized as one of the best medical schools in the nation, ranking 13th among research-oriented institutions, according to the latest U.S. News & World Report rankings.
Men with high-risk prostate cancer who received immunotherapy treatment with enoblituzumab in the weeks leading up to surgery had favorable rates of disease remission and tumor downgrading after surgery, according to a recent study published in Nature Medicine.
A novel protein developed by Northwestern Medicine investigators improved survival and prevented brain infection in mice infected with SARS-CoV-2 when administered intranasally, according to a recent study.
Ann & Robert H. Lurie Children’s Hospital of Chicago is the first in Illinois to receive designation as a NORD Rare Disease Center of Excellence, becoming one of 40 U.S. academic medical centers selected to be a part of the first-of-it-kind national network of U.S. medical institutions dedicated to diagnosing, treating, and researching all rare…
Richard Silverman, PhD, along with two other Northwestern faculty members, has been elected to the National Academy of Sciences.
Patients with endometrial cancer who received the immunotherapy drug pembrolizumab in addition to chemotherapy had longer progression-free survival compared to chemotherapy alone, according to a recent clinical trial published in the New England Journal of Medicine.
Northwestern University Feinberg School of Medicine has launched the new Simpson Querrey Lung Institute for Translational Science (SQLIFTS), ushering in a new era of lung research, education, and patient care at Northwestern Medicine.
Secondary bacterial pneumonia that did not resolve was a key driver of death in patients with COVID-19, according to a recent study in the Journal of Clinical Investigation.
Northwestern investigators have demonstrated that fine-tuning DNA interaction strength can improve colloidal crystal engineering to enhance their use in creating an array of functional nanomaterials.